A citation-based method for searching scientific literature

Ana M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, Huiqin Chen, Jennifer K Litton, Jennifer Potter, Jerry S Lanchbury, Katherine Stemke-Hale, Bryan T Hennessy, Banu K Arun, Gabriel N Hortobagyi, Kim-Anh Do, Gordon B Mills, Funda Meric-Bernstam. Clin Cancer Res 2011
Times Cited: 362



Fergus J Couch, Steven N Hart, Priyanka Sharma, Amanda Ewart Toland, Xianshu Wang, Penelope Miron, Janet E Olson, Andrew K Godwin, V Shane Pankratz, Curtis Olswold, Seth Slettedahl, Emily Hallberg, Lucia Guidugli, Jaime I Davila, Matthias W Beckmann, Wolfgang Janni, Brigitte Rack, Arif B Ekici, Dennis J Slamon, Irene Konstantopoulou, Florentia Fostira, Athanassios Vratimos, George Fountzilas, Liisa M Pelttari, William J Tapper, Lorraine Durcan, Simon S Cross, Robert Pilarski, Charles L Shapiro, Jennifer Klemp, Song Yao, Judy Garber, Angela Cox, Hiltrud Brauch, Christine Ambrosone, Heli Nevanlinna, Drakoulis Yannoukakos, Susan L Slager, Celine M Vachon, Diana M Eccles, Peter A Fasching. J Clin Oncol 2015
Times Cited: 393




List of shared articles



Times cited

Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients.
Leonora W de Boo, Katarzyna Jóźwiak, Heikki Joensuu, Henrik Lindman, Susanna Lauttia, Mark Opdam, Charlaine van Steenis, Wim Brugman, Roelof J C Kluin, Philip C Schouten,[...]. Br J Cancer 2022
0

Circulating Tumor Cells in Breast Cancer Patients: A Balancing Act between Stemness, EMT Features and DNA Damage Responses.
Benedikt Heitmeir, Miriam Deniz, Wolfgang Janni, Brigitte Rack, Fabienne Schochter, Lisa Wiesmüller. Cancers (Basel) 2022
0


Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Mary B Daly, Tuya Pal, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Michael Goggins, Mollie L Hutton,[...]. J Natl Compr Canc Netw 2021
131


Assessment of genetic referrals and outcomes for women with triple negative breast cancer in regional cancer centres in Australia.
Lucie G Hallenstein, Carol Sorensen, Lorraine Hodgson, Shelly Wen, Justin Westhuyzen, Carmen Hansen, Andrew T J Last, Julan V Amalaseelan, Shehnarz Salindera, William Ross,[...]. Hered Cancer Clin Pract 2021
1

A predictor of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients with the DNA repair genes.
Liang Huang, Guan-Tian Lang, Qi Liu, Jin-Xiu Shi, Zhi-Ming Shao, A-Yong Cao. Ann Transl Med 2021
0

An Overview of PARP Inhibitors for the Treatment of Breast Cancer.
Laura Cortesi, Hope S Rugo, Christian Jackisch. Target Oncol 2021
29

Influence of Family History of Breast or Ovarian Cancer on Pathological Complete Response and Long-Term Prognosis in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Marius Wunderle, Lothar Häberle, Alexander Hein, Sebastian M Jud, Michael P Lux, Carolin C Hack, Julius Emons, Felix Heindl, Naiba Nabieva, Christian R Loehberg,[...]. Breast Care (Basel) 2021
0

Germline and tumor BRCA1/2 pathogenic variants in Chinese triple-negative breast carcinomas.
Gang Ji, Longlong Bao, Qianlan Yao, Jing Zhang, Xiaoli Zhu, Qianming Bai, Zhiming Shao, Wentao Yang, Xiaoyan Zhou. J Cancer Res Clin Oncol 2021
0

Identification of a novel pathogenic variant in PALB2 and BARD1 genes by a multigene sequencing panel in triple negative breast cancer in Morocco.
Abdelilah Laraqui, Mathias Cavaillé, Nancy Uhrhammer, Oubaida ElBiad, Yannick Bidet, Hicham El Rhaffouli, Hicham El Anaz, Driss Moussaoui Rahali, Jaouad Kouach, Khaled Guelzim,[...]. J Genomics 2021
1

Expanding the Use of PARP Inhibitors as Monotherapy and in Combination in Triple-Negative Breast Cancer.
Mariya Yordanova, Audrey Hubert, Saima Hassan. Pharmaceuticals (Basel) 2021
0

BRCA1 and BRCA2 Germline Mutation Analysis in Hereditary Breast/Ovarian Cancer Families from the Aures Region (Eastern Algeria): First Report.
Chiraz Mehemmai, Farid Cherbal, Yosr Hamdi, Abdelmoumene Guedioura, Wassila Benbrahim, Rabah Bakour, Sonia Abdelhak. Pathol Oncol Res 2020
5

Triple negative breast cancer: A thorough review of biomarkers.
Jesse Lopes da Silva, Natalia Cristina Cardoso Nunes, Patricia Izetti, Guilherme Gomes de Mesquita, Andreia Cristina de Melo. Crit Rev Oncol Hematol 2020
66

53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients.
Fabienne Schochter, Kim Werner, Cäcilia Köstler, Anke Faul, Marie Tzschaschel, Barbara Alberter, Volkmar Müller, Hans Neubauer, Tanja Fehm, Thomas W P Friedl,[...]. Cancers (Basel) 2020
4

HRness in Breast and Ovarian Cancers.
Elizabeth Santana Dos Santos, François Lallemand, Ambre Petitalot, Sandrine M Caputo, Etienne Rouleau. Int J Mol Sci 2020
7


Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea.
Jai Min Ryu, Hee Jun Choi, Isaac Kim, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Se Kyung Lee, Doo Ho Choi, Yeon Hee Park, Jong-Won Kim,[...]. Breast Cancer Res Treat 2019
10

Chromosomal radiosensitivity of triple negative breast cancer patients.
Flavia Zita Francies, Olivia Herd, Alan Cairns, Sarah Nietz, Marshall Murdoch, Jacobus Slabbert, Kathleen B M Claes, Anne Vral, Ans Baeyens. Int J Radiat Biol 2019
2